MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 11..20 of 47 - per page Previous page Next page
Order by
This procedure allows the monitorization of respiration. This method is useful for identify compounds that regulate the activity of the UCPs. These compunds would be potential drugs to treat obesity or as antipyretic. More
Bitter taste receptor with potential application for improvement/masking of taste in foods and drugs More
This new technology is designed to screen for the autoantibodies for a spectrum of secreted tumor antigens in a single assay. More
The technology involves the characterization and identification of pulmonary stem cells as a target for viral infection. Application includes respiratory infection cell model, respiratory infection drug screening, lung tissue regenerative therapy More
This waveguide provides a significantly higher laser power delivery capability and higher damage threshold. More
Inventors at the National Institutes of Health have recently characterized and cloned both the yeast and human recombinant versions of the enzyme deoxyhypusine hydroxylase (DOHH) that catalyzes the final step in the modification of eIF5A. More
Unique distinctions of this design over other CNT based methods: complete isolation of the CNTs from chemical reactions concomitant with probe immobilization and target capture, and the CNTs functioning only as charge sensors. More
Methods for identifying a subject at increased risk for developing AMD by determining the presence of protective genotypes at either the BF/C2 locus and at the CFH locus. More
Discovery of novel coding sequence polymorphisms in the human TAS1R genes More
Sensitive detection and characterization of macromolecular interactions in homogenous or heterogeneous solutions of biological and/or synthetic macromolecules More
Displaying 11..20 of 47 - per page Previous page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us